08/02/2024

EuropaBio welcomes and warns on New Genomic Techniques European Parliament vote

The New Genomic Techniques (NGTs) legislation vote in the European Parliament is a welcome modernisation of Europe’s biotechnology innovation, food security and climate change response. However, EuropaBio red flags the dangerous fragmentation and weakening of industrial policy with the ban on patenting of NGT plants.
12/12/2023

EuropaBio Patient BioForum 2023: Roundtable on Advancing Solutions for Unmet Medical Needs

The EuropaBio Patient BioForum convened on 30 November 2023, bringing together a diverse group of stakeholders, including patient advocates, representatives from the biotech community, and European Institutions. Find the full Event Report and Press Release here.
02/11/2023

Factsheet – Supporting small biotechs in the revision of EU pharmaceutical legislation

Small biotech companies are the unsung heroes of the healthcare industry, driving innovation and improving patient access. They've been pivotal in developing transformative therapies and technologies. Collaboration is key to their success, but they face challenges.
09/10/2023

The Future of Health is Biotech: EuropaBio’s Position on the Revision of the EU Pharmaceutical Legislation

EuropaBio, the leading voice for the biotechnology industry in Europe, has released its position on the proposed revision of the EU General Pharmaceutical Legislation (GPL), underlining the vital role of biotech in shaping the future of healthcare.